0 false false false false false false false false false false true false false false false false false No description of principal activity 2023-05-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 08469180 2023-05-01 2024-04-30 08469180 2024-04-30 08469180 2023-04-30 08469180 2022-05-01 2023-04-30 08469180 2023-04-30 08469180 2022-04-30 08469180 bus:Director2 2023-05-01 2024-04-30 08469180 core:WithinOneYear 2024-04-30 08469180 core:WithinOneYear 2023-04-30 08469180 core:AfterOneYear 2024-04-30 08469180 core:AfterOneYear 2023-04-30 08469180 bus:Director2 2023-04-30 08469180 bus:Director2 2024-04-30 08469180 bus:Director2 2022-04-30 08469180 bus:Director2 2023-04-30 08469180 bus:Director2 2022-05-01 2023-04-30 08469180 bus:Director1 2023-05-01 2024-04-30 08469180 bus:Micro-entities 2023-05-01 2024-04-30 08469180 bus:AuditExempt-NoAccountantsReport 2023-05-01 2024-04-30 08469180 bus:SmallCompaniesRegimeForAccounts 2023-05-01 2024-04-30 08469180 bus:PrivateLimitedCompanyLtd 2023-05-01 2024-04-30 08469180 bus:FullAccounts 2023-05-01 2024-04-30
COMPANY REGISTRATION NUMBER: 08469180
Shriji Pharma Ltd
Filleted Unaudited Financial Statements
Year ended
30 April 2024
Shriji Pharma Ltd
Statement of Financial Position
30 April 2024
2024
2023
£
£
£
Fixed assets
2,697
1,936
-------
-------
Current assets
353,262
245,449
Creditors: amounts falling due within one year
170,680
108,137
---------
---------
Net current assets
182,582
137,312
---------
---------
Total assets less current liabilities
185,279
139,248
Creditors: amounts falling due after more than one year
6,500
12,500
Accruals and deferred income
1,700
1,700
---------
---------
177,079
125,048
---------
---------
Capital and reserves
177,079
125,048
---------
---------
Notes to the financial statements
1. Director's advances, credits and guarantees
During the year the director entered into the following advances and credits with the company:
2024
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mrs S Pipaliya
( 68,200)
( 1,109)
946
( 68,363)
--------
-------
----
--------
2023
Balance brought forward
Advances/ (credits) to the director
Amounts repaid
Balance outstanding
£
£
£
£
Mrs S Pipaliya
( 34,258)
( 34,000)
58
( 68,200)
--------
--------
----
--------
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 29 April 2025 , and are signed on behalf of the board by:
Mrs S Pipaliya
Director
Company registration number: 08469180
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Unit 3 Curo Park, Frogmore, St Albans, Hertfordshire, AL2 2DD, England.